My parents came to the US in the 90s for graduate school w/ little to nothing in search of their American dream. More than 3 decades later, here we are, living our dream: a family of doctors. I owe them everything & hope I’m making them proud 💖 Dad: MD, PhD Mom: PhD Me: MD

The week has shown again that health and humanitarian challenges are borderless. So must our efforts to strengthen health system resilience in Asia.

People with multiple myeloma and their doctors say that there are 6 main obstacles to getting a transplant. Read about this CIBMTR study to learn more: https://t.co/BjuKH5zROy

🤩 SO proud of my friend and colleague Dr @JamesFanWu who led our latest paper in @JCM_MDPI 📜 Using @IHME_UW data, we quantified three decades of trends in #hematologic #cancers across six #EastAsian countries 🩸 More in his #tweetorial! 🔗 https://t.co/5VbR2xE04z

7/ 🔗 Full paper: https://t.co/rpMkvNra1o #mmsm #lymsm #leusm #Hematology #CancerBurden #CancerEpidemiology #PublicHealth #GlobalHealth #GBD #GBD2021 #IHME #Asia #EastAsia #NCDs

6/ 🙏 Deeply grateful to our exceptional team for their insight, dedication & expertise. This work reflects the collective effort of an incredible international & multidisciplinary group. 💪 #TeamScience #HemeOnc #Trainees #CORGI

5/ 🎉 Proud to contribute to strengthening cancer epidemiology in Asia to help guide national cancer-control plans, shape oncology research agendas & support collaboration to reduce disparities in heme cancers across the region. 🔗

4/ 🌐 Why this matters: East Asia continues to shoulder a large & evolving heme cancer burden. Expanding diagnostics, strengthening access to novel therapies, improving survivorship systems & tailoring strategies to demographic shifts are urgent needs with global implications.

3/📊 Key trends: • 📈 Age-standardized incidence ↑ across many heme malignancies • 📉 Mortality & DALYs ↓ overall → improved detection + better therapy • 🔥 MM skyrocketed 200–300% in China, Mongolia & Taiwan, signaling a major emerging public-health challenge #mmsm

2/ 🌏 We evaluated leukemia subtypes, NHL, HL & MM across China 🇨🇳, Japan 🇯🇵, Mongolia 🇲🇳, Taiwan 🇹🇼, South Korea 🇰🇷 & North Korea 🇰🇵. 💡 This provides one of the most comprehensive regional assessments of heme cancer burden to date. #GBD2021 🔗

1/ 📢 New publication in @JClinMed_MDPI! We analyzed @IHME_UW GBD 2021 data to quantify 30 years of trends in heme cancers across six East Asian countries, revealing major shifts in incidence, mortality & overall cancer burden. 🔗 https://t.co/rpMkvNra1o #mmsm #lymsm #leusm

The Health Insurance Navigation Tools (HINT) intervention adapted for colorectal #cancer survivors: a pilot trial. https://t.co/j9rallL8kT @jcansurv @MassGeneralNews @MonganInstitute #FinancialToxicity #CancerCare #Survivorship #crcsm @PsycholERPark

Grateful to @JNCI_Now for the opportunity to write an editorial for excellent work by Dr @HanXuesong, @DrRobinYabroff, and team on #Medicaid expansion and #cancer during #Covid19 This piece is led by Drs @MilitSPatel @MirandaLamMD @Erin_Feliciano 🔗 https://t.co/1BkKQ9hZUP

Honored to have this work published in @NatRevClinOncol and disseminated to the broad audience that follows Nature Reviews Clinical Oncology. Thankful to Dr. Dee and Dr. Lee!

📜 Led by @MilitSPatel and Dr @IMRTLee, out in @NatRevClinOncol today: 👉 We highlight the importance of #synergy between #human #care and #AI-informed #medicine for people with #cancer. 👉 AI can #augment human expertise, not replace it. 🔗 https://t.co/nzdwn7qalh

Thank you @urotoday and Dr @zklaassen_md for the opportunity to present our work! @PCFnews @PCF_Science @MSK_RadOnc @MSKCancerCenter 🔗

A global investigation into the drivers of cancer care disparities. @EChrisDee @MSKCancerCenter sits down with @zklaassen_md @GACancerCenter to discuss global prostate cancer disparities and health system factors influencing outcomes. #WatchNow on UroToday >

Clearing the Stain: Rewriting the Story of Global Lung Cancer Policy | ASCO Connection https://t.co/ptx2WJhPao @iaslc @uicc @SylvesterCancer

7/ 🙏 Grateful to my incredible mentor Dr. Anita D’Souza for constant support & guidance. Huge thanks to Noel Estrada-Merly for tremendous help. 🙌 Thanks to Dr. Tina Yen, Dr. Yuhong Zhou & Bethany Canales from the @MCWCancerCenter Geo Core. Thank you @DHSWI & @ahwendowment!

6/ 📌 Using SVI + geospatial mapping, we provide a framework that can be adopted widely to: • identify vulnerable populations • uncover geographic gaps • guide equitable cancer care interventions locally, regionally, and nationally. 🔗 https://t.co/ElbSwpRQVe

5/💡 Access to transplant often reflects access to: • cutting-edge MM therapies like CAR-T • clinical trials These remain underutilized among socially vulnerable groups. Our findings highlight inequities that go far beyond transplant alone. 🔗 https://t.co/ElbSwpRQVe